Integration of biosafety surveillance through Biosafety Surveillance Conceptual Data Model

来源 :生物安全与健康英文 | 被引量 : 0次 | 上传用户:dgjklfkgl
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读

The global movement of people and goods has increased the risk of biosecurity threats and their potential to induce large economic, social, and environmental harm. Integration of biosafety monitoring networks has become a top priority for addressing biosafety issues. In order to resolve the data standards and integration problems in the field of biosafety in China, the Biosafety Surveillance Conceptual Data Model (BSCDM), which is an object-oriented, hierarchically designed, flexible and scalable biosafety surveillance concept data model, is proposed in this article. This model is based on the integration of business process management and data resources of disease surveillance, animal disease surveillance and potential invasive biological monitoring. In reference to the Public Health Conceptual Data Model (PHCDM) and Federal Enterprise Architecture (FEA), BSCDM conducts a thorough analysis of biosafety monitoring activities, records basic information requirements of biosafety monitoring and provides data set standards for biosafety-related activities. It is developed with the Unified Modeling Language (UML) and could be applied as an open standard for accelerating data analysis and promoting collaboration. This study attempts to integrate biosafety monitoring data and the presented model has been tested in the detection of dengue fever in China and will be applied to other biosafety fields.

其他文献
患者女,35岁,因"反复心悸3年"入院。经心内电生理检查及激动标测,确诊为右心房游离壁房性心动过速(房速)。先后行两次心内膜射频消融术后仍反复发作。第3次是在全身麻醉胸腔镜辅助下行心外膜射频消融术,手术成功,随访1年均未发作。经心内膜反复多次消融无效的无器质性心脏病的房速,需考虑联合心外膜消融,建议杂交手术,既心内膜、心外膜联合消融治疗房速,以提高手术成功率。
小儿病毒性心肌炎后遗留持续性三度房室传导阻滞伴心室扩大在考虑行永久性起搏器植入时,通常选择右心室心尖部或右心室流出道起搏,然而这种长期非生理起搏可能造成心脏泵功能下降以及房性心律失常发生。本例对1例2岁5个月的患儿选择左束支起搏方式,术后QRS时限仅82 ms,经过10个月随访,患儿左心室大小恢复、生活质量提高。本病例给需行永久起搏器的患儿提供了一个新的有前景的起搏方式。
慢性心力衰竭(CHF)发病率高,是65岁以上患者住院的首要原因,占心血管全因死亡率的1/3,5年生存率<50%。尽管目前β受体阻滞剂、血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体和醛固酮受体拮抗剂等药物的治疗及器械治疗如植入型心脏复律除颤器和心脏再同步治疗使很多患者获益,但CHF仍面临着高病死率的现状。近年来,CHF的自主神经干预的治疗逐渐兴起,一些临床前研究及临床试验显示了自主神经干预可在一定程度上
The positive pressure biological protective suit is the highest degree of personal protective equipment, and its performance directly impacts the health and safety of the wearer. Protection factor is
Yersinia pestis is the bacteria that causes plague, one of the deadliest diseases in human history. Three major plague pandemics (the Justinian Plague, the Black Death and the Modern Plague) have been
The launch of the new journal, Biosafety and Health, presents me with a unique opportunity to recount the progress of laboratory biosafety (LB) in China and my contribution to this area over the past
The human liver chimeric mouse is a milestone animal model for hepatitis B virus (HBV) infection. Such mice with primary human hepatocyte (PHH) transplantation are adequate to support chronic HBV infe
期刊
Human interaction with animals has been implicated as a primary risk factor for several high impact zoonoses, including many bat-origin viral diseases. However the animal-to-human spillover events tha
The paper examines the utility of codes of conduct for promoting responsible science and chemical, biological, radiological, and nuclear (CBRN) security education. It reviews the growing international